CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
atropine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00094692
NCT00094692Phase 3Completed
CompareCT.gov

An Evaluation of Treatment of Amblyopia in 7 To <18 Year Olds

Jaeb Center for Health Research·interventional·Posted Oct 22, 2004·Updated Mar 24, 2010

In Brief

A Phase 3 clinical trial evaluating Eye patch, spectacles, and 1 other intervention for Amblyopia. Completed, across 3 sites.

Detailed Summary

The goals of this study are: * To determine the response rate of treatment of amblyopia in 7 to \<18 year olds. * To determine the frequency of recurrence of amblyopia in 7 to \<18 year olds after discontinuation of amblyopia treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmblyopia
CountriesUnited States
CollaboratorsNational Eye Institute (NEI)

Timeline

Phase 3CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 22, 2004
Enrollment StartOct 1, 2002
Study CompletionDec 1, 2005
TodayJul 2, 2026
Posted 21.7 years ago

Interventions

Eye patchdevice

spectaclesdevice

atropinedrug